Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of care. Nevertheless, controversial reports have been published. The aim of the present study is to evaluate...
Автори: | Vasilis Petrakis, Vasiliki Rapti, Karolina Akinosoglou, Constantinos Bonelis, Kalomoira Athanasiou, Vasiliki Dimakopoulou, Nikolaos K. Syrigos, Nikolaos Spernovasilis, Grigoris Trypsianis, Markos Marangos, Charalambos Gogos, Dimitrios Papazoglou, Periklis Panagopoulos, Garyfallia Poulakou |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
MDPI AG
2022-09-01
|
Серія: | Microorganisms |
Предмети: | |
Онлайн доступ: | https://www.mdpi.com/2076-2607/10/10/1949 |
Схожі ресурси
Схожі ресурси
-
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice
за авторством: Nikos Pantazis, та інші
Опубліковано: (2023-08-01) -
The use of Remdesivir in pregnant women with COVID-19
за авторством: Gulbanu Shaimerdenova, та інші
Опубліковано: (2023-02-01) -
Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
за авторством: Karolina Akinosoglou, та інші
Опубліковано: (2023-05-01) -
Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
за авторством: Richard D. Shih, та інші
Опубліковано: (2020-12-01) -
Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center
за авторством: Mahendra Munirathnam, та інші
Опубліковано: (2021-01-01)